Drug Manufacturers
BHC Stock Closes Up 9%: Bausch 2019 Outlook Increased After Successful Q1
On Monday, May 6, BHC stock jumped nearly 10% after Bausch Health Companies (TSX:BHC) announced its Q1 2019 results and increased its 2019 outlook. Here’s what we know. BHC Stock Up On Bausch Earnings Formerly ... [Read]
biotechnology
ImmunoPrecise to Present at the 2019 Bloom Burton and Co. Healthcare Investor Conference
VICTORIA, April 16, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd. (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”)announced today that Jennifer Bath, President and CEO of ImmunoPrecise Antibodies, will present at the upcoming 2019 Bloom Burton & Co. Healthcare Investor Conference. Date: May 1st, ... [Read]
biotechnology
ImmunoPrecise Appoints Andy Nixon to Board of Directors
VICTORIA, April 11, 2019 / – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”) announces that it has appointed Andy Nixon, Vice President of Biotherapeutics Molecule Discovery at Boehringer Ingelheim, as a member of its board of ... [Read]
Biotechnology
Advaxis Shares Pop Up 72% On Solid Data For ADXS-NEO
Shares of Advaxis (NASDAQ:ADXS) are up a whopping 72%, selling for $10.20 this morning after the company released improved data for its personalized cancer vaccine candidate ADXS-NEO. The stock is up about 32% year to date ... [Read]
health
ImmunoPrecise Antibodies Receives Subcontract to Produce Rabbit Monoclonal Antibodies
VICTORIA, Feb. 21, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd. (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”) has received a five-year Indefinite Delivery/Indefinite Quantity (ID/IQ) subcontract from Leidos Biomedical Research, Inc., which currently operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute ... [Read]
health
ImmunoPrecise Antibodies Announces DTC Eligibility
VICTORIA, BC, Feb. 28, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd. (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”) is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ... [Read]
Pharmaceutical
Purdue Pharma Explores Bankruptcy After Thousands of Lawsuits
OxyContin-maker Purdue Pharma LP is exploring bankruptcy to prepare for the thousands of lawsuits filed against the company, Reuters reported early this morning. An official statement has yet to be released by the private pharmaceutical company ... [Read]
Healthcare
Johnson & Johnson Investigation: Shares Fall Again Over Asbestos
Another Johnson & Johnson investigation (NYSE:JNJ) is underway, and JNJ shares have taken a nosedive in response. Once again, the company is being investigated for asbestos contamination. JNJ shares dived from $136.39 USD to $134.55 USD ... [Read]
Pharmaceutical
JNJ Stock: Johnson & Johnson Misses Analyst Target for Forecast 2019 Sales
Johnson & Johnson (JNJ) (NYSE:JNJ) released its forecast 2019 sales earlier today. The pharmaceutical giant fell short of analyst estimates after previously reporting better-than-expected Q4 results. On the news, JNJ stock is down -2.06%, selling for ... [Read]
Drug Manufacturers
US Drug Companies Raise Med Prices Despite President Trump Pressure
2019 is not kicking off to a great start for most Americans. US drug companies kicked off the year implementing price increases on more than 250 prescription drugs—despite pressure from President Trump to not do ... [Read]